Interestingly, through MR analysis, we identified TNFRSF11B, TNF alpha induced protein 3 (TNFAIP3), TNF superfamily member 12 (TNFSF12) as potentially protective factors against vitiligo, which may explain why some patients experience depigmentation after using TNF inhibitors. This evidence concerns the gene TNFAIP3 and vitiligo.